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Promoter Polymorphism at –238 of the Tumor Necrosis
Factor Alpha Gene is Not Associated with Early Onset
Psoriasis when Tested by the Transmission
Disequilibrium Test
To the Editor:
Psoriasis vulgaris is a chronic inflammatory and hyperproliferative
skin disease that has a complex genetic basis including a paternal
effect (Traupe et al, 1992; Burden et al, 1998). Gene mapping
studies have disclosed a susceptibility locus within the HLA region
on chromosome 6p (Trembath et al, 1997; Nair et al, 1997; Burden
et al, 1998). This region contains a number of genes that are
involved in the regulation and modulation of inflammatory reactions
and from a pathophysiologic perspective are potential candidate
genes for psoriasis. One of these genes is the tumor necrosis factor
(TNF)-α that in vitro has an antiproliferative effect on normal
human keratinocytes (Malkani et al, 1993).
A mutation in the promoter region of the TNF-α gene at
position –308 relative to the transcriptional start of the gene is
associated with a higher constitutive and inducible transcription of
the gene (Wilson et al, 1997). A second polymorphism in the
promoter region has been identified at position –238, but the
functional consequences of this mutation are not yet clear (Pociot
et al, 1995).
Recently, Ho¨hler et al (1997) reported in this journal an
association between this latter polymorphism of the TNF-α gene
and early onset psoriasis, and for the polymorphism at position
–308 similar proportions were found in patients and controls.
Ho¨hler et al performed a classical case/control designed study and
examined 60 patients with psoriasis vulgaris of early onset and 99
controls derived from routine paternity cases studied at the Institute
of Legal Medicine from Mainz, Germany.
We found the results of Ho¨hler et al very intriguing and therefore
decided to examine a second cohort of German psoriasis patients
with regard to the TNF-α promoter polymorphism at –238, and
were especially interested whether there would be differences
between paternal and maternal cases. This latter question is of
interest because of the paternal effect associated with the 6p psoriasis
susceptibility locus (Burden et al, 1998).
To evaluate the suggested association we decided to use the
transmission disequilibrium test (TDT) (Spielman et al, 1993). For
the TDT trios comprising a proband and his two parents are
studied, and the test considers parents who are heterozygous for
an allele associated with disease and evaluates the frequency with
which that allele is transmitted to affected offspring. In each trio
the untransmitted alleles of the parents serve as a control.
Altogether 83 index patients (40 females and 43 males) from the
Department of Dermatology of the University of Mu¨nster, of the
Bad Bentheim Fachklinik and of the University of Berlin (Charite´
hospital) suffering from psoriasis vulgaris of early onset were studied
and EDTA blood was drawn for DNA analysis from them and
from their parents. To do this, usually visits at the home of these
nuclear families were organized. During these visits both parents
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were also examined clinically to establish whether or not they were
affected by psoriasis vulgaris.
Twenty of the index cases had an affected father (24%) and 22
had an affected mother (27%), whereas 41 cases (49%) were sporadic
and no family history could be obtained. The mean age of onset
of psoriasis in the index patients was 12.8 y for females compared
with 16.51 y in male index patients.
In all trios a 328 bp fragment – from nucleotide 396 until
nucleotide 69 of the 59 region of the TNF-α gene – was
amplified using the TNF forward primer from the nucleotide
–396(59-TTCCTGCATCCTGTCTGGAA-39) and the reverse
primer from TNF-69 (59-CAGCGGAAAACTTCCTTGGT-39)
(D’Alfonso and Richiardi, 1994). The polymerase chain reaction
products were separated electrophoretically on a 2% agarose gel
and then vacuum-blotted onto a Biodyne-B-Membrane. To
identify the promoter polymorphisms we used radioactively end-
labeled allele specific oligonucleotides. For the mutation at
–238 the oligonucleotides 59-CCCTGCTCCGATTCCGAG-39
and 59-CCTCGGAATCAGAGCAGGG-39 (D’Alfonso and
Richiardi, 1994) were used. The hybridization temperature was
58°C and the wash out started with a temperature of 60°C and
was repeated three times with an increment of 2°C each time. For
the –308 polymorphism the oligonucleotides 59CCCGT-
CCCCATGCCCCT-39 and 59-AGGGGCATGAGGACGGGG-
39 and a hybridization temperature of 63°C were used. The
wash out started with 65°C and was repeated four times with a
temperature increment of 2°C every time.
A total of 30 patients were additionally sequenced using a
polymerase chain reaction-based sequencing technique.
For statistical analysis the TDT test as modified by Terwilliger
(1995) was used. Analyses were carried out for the entire group
and for cases with a maternal and paternal transmission separately.
Similar to Ho¨hler et al (1997) we find no association between
the polymorphism at –308 of the TNF-α gene and psoriasis. When
we look at the data from the control group of Ho¨hler et al (1997)
concerning the –238 locus, then the G/A constellation is found
only in 7% of their controls and there are no homozygotes. We
have used these control group data and compared them with those
found in our index patient group. When we follow this kind of
design used by Ho¨hler we find a seemingly strong association (p 5
0.001; Table I); however, when tested by the TDT (Table II) we
cannot confirm an association and find a p value of 0.10. Likewise,
the separate analysis of paternally transmitted cases resulted in a p
value of 0.28 and of maternally transmitted cases in a p value of 0.5.
To address the question why the TDT does not confirm the
result obtained in the case control design, we decided to check the
validity of the control group by performing a Hardy Weinberg
equilibrium test. For the –238 polymorphism the allele distribution
followed the genetic expectations, whereas this was clearly not the
case for the –308 variant (Table III). This lack of a genetic
equilibrium for the allele distribution in the Mainz control group
suggests that these controls are not a representative population
sample.
We conclude that the association found in our patients in the
case control design using the Mainz control group data cannot be
confirmed when a TDT is performed. This casts doubts on the
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Table I. Evaluation of TNF-a promoter polymorphisms
by Chi-square test under a case/control design
Index patients Controls
with psoriasis Parents (Mainz Data)
n % n % n %
TNF-α –238a
G/G 57 69 127 77 92 93
G/A 26 31 39 24 7 7
A/A 0 0 0 0 0 0
Total 83 166 99
TNF-α –308b
G/G 61 75 112 69 73 74
G/A 18 22 43 27 20 20
A/A 1 1 1 1 6 6
Total 81 162 99
aTest statistics for TNF-α –238: G/A and A/A versus G/G for index patients versus
Mainz controls taken from Ho¨hler et al (1997) gives Chi square of 16.193, p 5 0.001.
bTest statistics for TNF-α –308: G/A and A/A versus G/G for index patients versus
Mainz controls taken from Ho¨hler et al (1997) gives Chi square of 1.147, p 5 0.284.
Table II. Evaluation of TNF-a promoter polymorphisms
by TDT
Transmitted alleles Untransmitted TDTa One-sided
in heterozygous alleles in parents p valueb
index patients
TNF-α –238c
G 15 26 2.95 0.99
A 26 15 0.11
TNF-α –308d
G 24 19 0.58 0.47
A 19 24 0.58 0.97
aThe alpha test version for computing TDT-like likelihood ratio statistics based
on Terwilliger (1995) was used.
bSeparate evaluation of paternal transmission gave for the –238 locus a p value of
0.28 and for the –308 locus a p value of 0.50. Likewise maternal transmission gave
a p value of 0.50 for the –238 locus and a p value of 0.43 for the –308 locus.
cMaximum likelihood estimate of TDT lambda 5 0.64, p value 5 0.10.
dMaximum likelihood lambda 5 0.50, p value 5 0.50.
Table III. Test for Hardy–Weinberg-Equilibrium in the
Mainz control group for the –308 polymorphism
Chi-square (total, DF 5 1) 6.413165
Probability (Chi-square, DF 5 1) 0.011328
Observed G/G 73
Expected G/G 69.59
Chi-square 0.167510
Observed G/A 20
Expected G/A 26.83
Chi-square 1.737921
Observed A/A 6
Expected A/A 2.59
Chi-square 4.507734
Conclusion: There is a significant deviation from a
Hardy–Weinberg-equilibrium in the control group.
validity of the results obtained in the case control study of Ho¨hler
et al (1997), because the design of case control studies allows for
type 1 errors that can occur when the control group does not
truely represent the general population. In contrast, the TDT
circumvents the difficult matching of the control group as it
considers as a control the untransmitted alleles of the parents.
Therefore the TDT is today considered as a powerful instrument
in genetic studies of complex diseases and recently allowed, for
example, the mapping of a locus for autistic disorders (Cook
et al, 1998).
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Reply
Traupe et al have investigated the allele distribution of polymorph-
isms in the promoter of the tumor necrosis factor (TNF)-α gene,
which is encoded within the major histocompatibility complex
(MHC), in patients with familial and sporadic psoriasis. In contrast
to two previously published papers (Arias et al, 1997; Ho¨hler et al,
1997) that reported a highly significant association of familial cases
with type 1 psoriasis with the TNF238.2 allele (A at position –
238), the authors found no association in their study using the
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